IN-VITRO PERMEABILITY OF PEPTIDOMIMETIC DRUGS - THE ROLE OF POLARIZEDEFFLUX PATHWAYS AS ADDITIONAL BARRIERS TO ABSORPTION

Citation
Ps. Burton et al., IN-VITRO PERMEABILITY OF PEPTIDOMIMETIC DRUGS - THE ROLE OF POLARIZEDEFFLUX PATHWAYS AS ADDITIONAL BARRIERS TO ABSORPTION, Advanced drug delivery reviews, 23(1-3), 1997, pp. 143-156
Citations number
114
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
0169409X
Volume
23
Issue
1-3
Year of publication
1997
Pages
143 - 156
Database
ISI
SICI code
0169-409X(1997)23:1-3<143:IPOPD->2.0.ZU;2-4
Abstract
Cellular efflux pathways function to remove both endogenous and exogen ous substances from the cell. In the case of a polarized cellular barr ier. such as the epithelium, these pathways serve an excretory or secr etory role in transporting solutes out of tissue. Although well recogn ized in organs typically associated with drug excretion such as liver and kidney, similar transport pathways have been found in other tissue s including the intestinal mucosa and the endothelial cells comprising the blood-brain barrier. Current evidence suggests that these systems may act as barriers to drug absorption into the tissues in which they are found. More recent studies have shown that hydrophobic peptides s uch as cyclosporin A are substrates for polarized efflux. In this revi ew we examine the evidence for these mechanisms as absorption barriers and the use of in vitro transport models for characterizing this phen omenon. The presence of such pathways may help explain the poor membra ne permeability of peptides which, along with metabolism. contributes to their poor in vivo performance.